NIH clinical trial of hydroxychloroquine, a potential therapy for COVID-19, begins | National Heart, Lung, and Blood Institute (NHLBI)

NIH clinical trial of hydroxychloroquine, a potential therapy for COVID-19, begins | National Heart, Lung, and Blood Institute (NHLBI)

NIH Begins Clinical Trial of a Potential Treatment for COVID-19 Patients in Tennessee are the first to enroll in an NHLBI clinical trial to study the safety and effectiveness of hydroxychloroquine to treat COVID-19. The study aims to enroll more than 500 adults who are hospitalized with COVID-19.   Read more about this NIH clinical trial.